Compensatory & Neuronal Health Mechanisms

In PD research, the biological processes that compensate for the loss of dopaminergic neurons in the course of disease progression such that the onset of motor symptoms is only observable after a large percentage of dopaminergic cells is lost are referred to in the literature as compensatory mechanisms.  Similar processes may be presumed to operate to delay the surfacing of non-motor symptoms that result from neurodegeneration in PD, but there is little evidence of this at present (Bezard et al., 2009).

Compensatory mechanisms may or may not include well known examples of cellular processes known to enhance neuronal health and development such as neurotrophic factors; there are several attempts to enlist these factors as means of countering or repairing neurodegeneration.

Neurotrophic factors are secreted growth factors that can signal growth and differentiation, and block programmed cell death pathways. There is also clear evidence that new neurons can be generated in at least some regions of the adult brain, suggesting that this process could be used to repair damage to the brain. It is unclear whether disruption of these protective and/or restorative mechanisms is a direct cause of or reaction to PD, but research has focused on attempts to use the mechanisms for therapeutic purposes.

Reference: 
Bezard E, Porras G, Blesa J, Obeso JA. Compensatory mechanisms in experimental and human parkinsonism: potential for new therapies. In: Steiner H, Tseng KY, editors. Handbook of Basal Ganglia Structure and Function: A Decade of Progress. San Diego: Elsevier; 2009.
0
24 Feb 2010
There are an abundence of emerging pathological and imaging studies from patients with Lewy Body diseases which strongly suggest that non-dopaminergic neurons are dysfunctional at early ... 
14 Dec 2009
P1.217 Decreased putamen aldehyde dehydrogenase in Parkinson disease D. Goldstein, P. Sullivan, C. Holmes, I. Kopin, M. Basile ... 
16 Nov 2009
There was a time when the idea of hiring a company to perform some experimental procedures was unheard of in academic research circles.  Now the use of contract research organizations (CROs) is ... 
24 Feb 2010
An important step in moving novel neuroprotective agents towards the clinic involves testing the efficacy of therapeutics in preclinical models.  Many different preclinical models are available ... 
Responses: 15
04 Sep 2009
Loss of dopaminergic suppression (leading to greater activity) of the 'indirect' striatopallidal pathway in the basal ganglia is believed to be a possible cause of motor loss in people with ... 
Responses: 1
29 Apr 2009
Neurotrophic factors have great potential as neuroprotective drugs for Parkinson's disease but their delivery from the blood to the brain is poor, necessitating neurosurgical strategies to achieve ... 
Responses: 1
30 Jun 2009
This Funding Opportunity Announcement (FOA) is a program announcement (PA) issued by the National Institute of Neurological Disorders and Stroke (NINDS), the National Eye Institute (NEI), the ... 
11 Jun 2009
Brief Description:This Funding Opportunity Announcement (FOA) issued by the National Institute of Neurological Disorders and Stroke (NIINDS), Eunice Kennedy Shriver National Institute of Child Health ... 
11 Jun 2009
Brief Description:The aim of this FOA is to invite applications to study angiogenesis in the nervous system. Specific areas of research this FOA seeks to encourage include study of the mechanisms ... 
Potential PD therapies that aim at replacing lost dopaminergic innervation have several challenges to overcome:  getting new dopaminergic neuronal growth to occur at all is one major challenge, ... 
22 Sep 2009
Responses: 1
Published last week in PNAS, Dr. Ronald McKay and colleagues discover a new neuronal precursor cell. Administration of a cocktail of growth factors stimulating these cells led to improvement in a rat ... 
31 Jul 2009
Published today in Cell, Bersell et al. demonstrate the trophic factor Neuregulin1 and its receptor, tyrosine-kinase receptor ErbB4, can promote proliferation of cardiomyocytes, thought to be ... 
24 Jul 2009